Placebo Effect of Sham Acupuncture for Primary Insomnia: A Meta-Analysis of Randomised Controlled Trials.

Researchers analyzed 36 clinical trials to understand whether sham acupuncture (a placebo treatment where needles don't penetrate the skin or are placed at non-therapeutic points) can improve sleep in people with primary insomnia. Primary insomnia means difficulty sleeping that isn't caused by another medical condition, medication, or substance use.

The study found that patients receiving sham acupuncture showed meaningful improvements in their sleep quality scores. Specifically, their Pittsburgh Sleep Quality Index (a questionnaire measuring sleep quality) improved by an average of 1.38 points, and their Insomnia Severity Index scores improved by 2.58 points. These improvements suggest that the placebo effect in acupuncture trials for insomnia is real and measurable.

Interestingly, while patients reported feeling better on questionnaires, objective sleep measurements using devices like polysomnography (sleep studies) and actigraphy (wrist-worn activity monitors) didn't show significant changes. This suggests the improvements may be more about how patients perceive their sleep quality rather than actual changes in sleep architecture.

What does this mean for you? If you're considering acupuncture for insomnia, these findings suggest that some of acupuncture's benefits might come from placebo effects—the therapeutic ritual, practitioner attention, and expectation of improvement. However, this doesn't mean the treatment isn't valuable. Placebo effects are real physiological responses that can genuinely improve symptoms. The study also notes that different types of sham acupuncture produced varying effects, suggesting that the specific technique matters.

If you're interested in trying acupuncture for sleep problems, seek treatment from a qualified, licensed acupuncturist who can provide comprehensive evaluation and individualized care.

This meta-analysis of 36 RCTs examined the placebo effect of sham acupuncture in primary insomnia patients. The study included 4,348 initially screened studies, with risk of bias assessment showing 16 low-risk, 7 some-concerns, and 13 high-risk studies using Cochrane RoB 2.0 tool.

Key findings demonstrated statistically significant improvements in subjective sleep measures: PSQI showed a weighted mean difference of 1.38 points (95% CI: 0.90-1.86, p<0.05), and ISI improved by 2.58 points (95% CI: 1.46-3.69, p<0.05). However, objective measures including polysomnography and actigraphy showed no significant changes.

The discrepancy between subjective and objective outcomes suggests the placebo response in acupuncture trials involves perception-based improvements rather than measurable sleep architecture changes. The authors noted heterogeneity in placebo effects across different sham acupuncture methodologies.

Clinical implications: When designing acupuncture RCTs for insomnia, practitioners should recognize the substantial placebo component (approximately 1-2.5 points on standard scales) and consider incorporating both subjective and objective outcome measures. Understanding placebo magnitude helps contextualize true treatment effects in clinical research and practice.